PHARMACEUTICALS AND VIRAL SAFETY: A GLOBAL VIEW
	Institut Pasteur , Paris, France March 2-3, 2000
	·F. Horaud (F): Viral safety of biological products: an historical survey ·R. Hay (USA): Cell banks and the concept of sterility and purity ·A.R. Shaw (USA): How biological materials are tested for safety ·J. Petricciani (USA): Should we continue to worry about cell substrates ·G. Siegl (CH): Significance of Parvoviruses as contaminants in products of mammalian origin ·J. Löwer (D): Endogenous Retroviruses: Viruses in all of us, humans and animals ·J.S. Robertson (UK): Enveloped viruses: structure and resistance to physico-chemical treatment ·F. Brown (USA): Naked viruses: structure and resistance to physico-chemical treatments ·P.D. Minor (UK): Critical overview of methods currently used for viral inactivation: limits and advantages ·A. Bradburne (UK): Nanofiltration: viral elimination versus industrial constraints ·D. Larzul (F): Viral validation design ·R. Garnick (USA): A multifaceted approach to assure the viral safety of recombinant proteins ·M.R. Hilleman (USA): Problems, hurdles, triumphs and future of live virus vaccines ·B. Mahy (USA): Recent emergence of new virus diseases. An overview ·M. Eloit (F): Species barrier and transmission of viruses to human ·J.W. Wilesmith (UK): Bovine Spongiform Encephalopaty: lessons from the epidemiology of the disease ·D. Dormont (F): Transmissible Spongiform Encephalopaties and the enigma of etiological agents ·R.G. Will (GB) Creutzfeldt-Jakob disease and its new variant ·N. Dumey (F): Viral risk and gene therapy ·F.-L. Cosset (F): Safety of MLV vectors ·L. Naldini (I): Lentiviral vectors: design, biosafety and quality control assays ·A. Yver (USA): Clinical biosafety of RPR/INGN201 (Ad5CMVp53) in 200+ patients with head & neck cancer ·P. Moullier (F): Use of AAV Vectors in non human primates: viral safery issue ·J. Purves (UK): Global european strategy for viral safety of pharmaceuticals
	Organized by:	Institut Pasteur
	Invited Speakers:	Scientific Committee: O. Danos F. Horaud D. Larzul A.R. Shaw
	Deadline for Abstracts:	January 3, 2000
	Registration:	Institut Pasteur EuroConferences 28 rue du Docteur Roux 75724 Paris Cedex 15, France. fax: 33 (0)1 40 61 34 05 http://www.pasteur.fr/applications/euroconf/
	Email for Requests and Registration:	ldrye@pasteur.fr
	Posted by: Drye Ludovic   Host: 157.99.64.24 date: December 13, 1999 17:51:10 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.